Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2013-03-28 Regulatory Filings
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT ON RESUMPTION OF TRADING IN THE SHARES
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the resumption of trading of the company's shares after a suspension. It discusses the forensic review report and internal control review conducted by independent parties, the Audit Committee's assessment, and the company's fulfillment of conditions set by the stock exchange for resumption of trading. The document is an announcement of these findings and actions, not the forensic or internal control reports themselves. It is not a full financial report, earnings release, or management report, but rather a regulatory announcement related to trading status and compliance. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2013-03-28 English
ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement from the Board of Directors of a company listed on the Hong Kong Stock Exchange. It provides an update on the progress of the application for resumption of trading of the company's shares. The content focuses on the forensic review conducted by an independent professional accountant regarding past transactions and internal controls, summarizing findings and conclusions. There are references to previous announcements and ongoing discussions with the Exchange. The document does not contain full financial statements or detailed financial performance data, nor is it a transcript, presentation, or voting result. It is a regulatory update related to compliance and trading status rather than a full report or financial disclosure. The length is moderate (7,407 characters), and the document is clearly an announcement rather than a full forensic or audit report. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance updates that do not fit other specific categories.
2013-03-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2013
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28 February 2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document is not an annual or interim report, earnings release, or management discussion. It is a regulatory compliance report specific to share capital movements, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2013-03-04 English
List of Directors and their Role and Function
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles, including committees such as the Audit Committee, Remuneration Committee, and Nomination Committee. It does not contain financial data, earnings, or report content. It is an announcement related to board and management information, specifically about the composition and roles of the board members. The document length is short and focused solely on board composition, fitting the category of Board/Management Information (MANG).
2013-02-27 English
ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to Rule 13.09 of the Listing Rules, concerning the progress of the application for resumption of trading of the company's shares on the Hong Kong Stock Exchange. It references previous announcements and discusses ongoing discussions with the Exchange. The document is short (2099 characters) and does not contain any financial statements, detailed financial data, or report content. It is clearly an update or announcement about a regulatory or trading status matter rather than a full report or financial filing. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2013-02-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2013
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 January 2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during a specific month. It is a regulatory filing reporting monthly share capital movements rather than a financial report, earnings release, or management discussion. The document is not an announcement of a report publication but a detailed regulatory submission. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2013-02-06 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.